Literature DB >> 20377613

Biochemical and functional properties of distinct nicotinic acetylcholine receptors in the superior cervical ganglion of mice with targeted deletions of nAChR subunit genes.

Reinhard David1, Anna Ciuraszkiewicz, Xenia Simeone, Avi Orr-Urtreger, Roger L Papke, J M McIntosh, Sigismund Huck, Petra Scholze.   

Abstract

Nicotinic acetylcholine receptors (nAChRs) mediate fast synaptic transmission in ganglia of the autonomic nervous system. Here, we determined the subunit composition of hetero-pentameric nAChRs in the mouse superior cervical ganglion (SCG), the function of distinct receptors (obtained by deletions of nAChR subunit genes) and mechanisms at the level of nAChRs that might compensate for the loss of subunits. As shown by immunoprecipitation and Western blots, wild-type (WT) mice expressed: alpha 3 beta 4 (55%), alpha 3 beta 4 alpha 5 (24%) and alpha 3 beta 4 beta 2 (21%) nAChRs. nAChRs in beta 4 knockout (KO) mice were reduced to < 15% of controls and no longer contained the alpha 5 subunit. Compound action potentials, recorded from the postganglionic (internal carotid) nerve and induced by preganglionic nerve stimulation, did not differ between alpha 5 beta 4 KO and WT mice, suggesting that the reduced number of receptors in the KO mice did not impair transganglionic transmission. Deletions of alpha 5 or beta2 did not affect the overall number of receptors and we found no evidence that the two subunits substitute for each other. In addition, dual KOs allowed us to study the functional properties of distinct alpha 3 beta4 and alpha 3 beta 2 receptors that have previously only been investigated in heterologous expression systems. The two receptors strikingly differed in the decay of macroscopic currents, the efficacy of cytisine, and their responses to the alpha-conotoxins AuIB and MII. Our data, based on biochemical and functional experiments and several mouse KO models, clarify and significantly extend previous observations on the function of nAChRs in heterologous systems and the SCG.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20377613      PMCID: PMC2989642          DOI: 10.1111/j.1460-9568.2010.07133.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  63 in total

1.  Alpha subunit composition of nicotinic acetylcholine receptors in the rat autonomic ganglia neurons as determined with subunit-specific anti-alpha(181-192) peptide antibodies.

Authors:  M V Skok; L P Voitenko; S V Voitenko; E Y Lykhmus; E N Kalashnik; T I Litvin; S J Tzartos; V I Skok
Journal:  Neuroscience       Date:  1999       Impact factor: 3.590

2.  Megacystis, mydriasis, and ion channel defect in mice lacking the alpha3 neuronal nicotinic acetylcholine receptor.

Authors:  W Xu; S Gelber; A Orr-Urtreger; D Armstrong; R A Lewis; C N Ou; J Patrick; L Role; M De Biasi; A L Beaudet
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-11       Impact factor: 11.205

3.  Selective deletion of the alpha5 subunit differentially affects somatic-dendritic versus axonally targeted nicotinic ACh receptors in mouse.

Authors:  Harald Fischer; Avi Orr-Urtreger; Lorna W Role; Sigismund Huck
Journal:  J Physiol       Date:  2004-12-20       Impact factor: 5.182

4.  Four pharmacologically distinct subtypes of alpha4beta2 nicotinic acetylcholine receptor expressed in Xenopus laevis oocytes.

Authors:  R Zwart; H P Vijverberg
Journal:  Mol Pharmacol       Date:  1998-12       Impact factor: 4.436

5.  Somatic and prejunctional nicotinic receptors in cultured rat sympathetic neurones show different agonist profiles.

Authors:  D Kristufek; E Stocker; S Boehm; S Huck
Journal:  J Physiol       Date:  1999-05-01       Impact factor: 5.182

6.  Hidden function of neuronal nicotinic acetylcholine receptor beta2 subunits in ganglionic transmission: comparison to alpha5 and beta4 subunits.

Authors:  Ningshan Wang; Avi Orr-Urtreger; Joab Chapman; Yusuf Ergün; Ruth Rabinowitz; Amos D Korczyn
Journal:  J Neurol Sci       Date:  2005-01-20       Impact factor: 3.181

7.  Identification of four classes of brain nicotinic receptors using beta2 mutant mice.

Authors:  M Zoli; C Léna; M R Picciotto; J P Changeux
Journal:  J Neurosci       Date:  1998-06-15       Impact factor: 6.167

8.  Chronic nicotine treatment up-regulates human alpha3 beta2 but not alpha3 beta4 acetylcholine receptors stably transfected in human embryonic kidney cells.

Authors:  F Wang; M E Nelson; A Kuryatov; F Olale; J Cooper; K Keyser; J Lindstrom
Journal:  J Biol Chem       Date:  1998-10-30       Impact factor: 5.157

9.  alpha 5 Subunit alters desensitization, pharmacology, Ca++ permeability and Ca++ modulation of human neuronal alpha 3 nicotinic receptors.

Authors:  V Gerzanich; F Wang; A Kuryatov; J Lindstrom
Journal:  J Pharmacol Exp Ther       Date:  1998-07       Impact factor: 4.030

10.  alpha-conotoxin AuIB selectively blocks alpha3 beta4 nicotinic acetylcholine receptors and nicotine-evoked norepinephrine release.

Authors:  S Luo; J M Kulak; G E Cartier; R B Jacobsen; D Yoshikami; B M Olivera; J M McIntosh
Journal:  J Neurosci       Date:  1998-11-01       Impact factor: 6.167

View more
  26 in total

1.  Function of human α3β4α5 nicotinic acetylcholine receptors is reduced by the α5(D398N) variant.

Authors:  Andrew A George; Linda M Lucero; M Imad Damaj; Ronald J Lukas; Xiangning Chen; Paul Whiteaker
Journal:  J Biol Chem       Date:  2012-06-04       Impact factor: 5.157

2.  α-Conotoxin PeIA[S9H,V10A,E14N] potently and selectively blocks α6β2β3 versus α6β4 nicotinic acetylcholine receptors.

Authors:  Arik J Hone; Mick'l Scadden; Joanna Gajewiak; Sean Christensen; Jon Lindstrom; J Michael McIntosh
Journal:  Mol Pharmacol       Date:  2012-08-22       Impact factor: 4.436

3.  Impact of human D398N single nucleotide polymorphism on intracellular calcium response mediated by α3β4α5 nicotinic acetylcholine receptors.

Authors:  Anne Tammimäki; Penelope Herder; Ping Li; Caroline Esch; James R Laughlin; Gustav Akk; Jerry A Stitzel
Journal:  Neuropharmacology       Date:  2012-07-20       Impact factor: 5.250

4.  α4β2 nicotinic acetylcholine receptors in the early postnatal mouse superior cervical ganglion.

Authors:  Petra Scholze; Anna Ciuraszkiewicz; Florian Groessl; Avi Orr-Urtreger; J Michael McIntosh; Sigismund Huck
Journal:  Dev Neurobiol       Date:  2011-05       Impact factor: 3.964

Review 5.  Nicotinic acetylcholine receptors in neuropathic and inflammatory pain.

Authors:  Arik J Hone; J Michael McIntosh
Journal:  FEBS Lett       Date:  2017-10-27       Impact factor: 4.124

6.  PeIA-5466: A Novel Peptide Antagonist Containing Non-natural Amino Acids That Selectively Targets α3β2 Nicotinic Acetylcholine Receptors.

Authors:  Arik J Hone; Fernando Fisher; Sean Christensen; Joanna Gajewiak; David Larkin; Paul Whiteaker; J Michael McIntosh
Journal:  J Med Chem       Date:  2019-06-27       Impact factor: 7.446

Review 7.  Nicotinic regulation of energy homeostasis.

Authors:  Michele Zoli; Marina R Picciotto
Journal:  Nicotine Tob Res       Date:  2012-09-18       Impact factor: 4.244

Review 8.  Merging old and new perspectives on nicotinic acetylcholine receptors.

Authors:  Roger L Papke
Journal:  Biochem Pharmacol       Date:  2014-01-31       Impact factor: 5.858

9.  Expression of α3β2β4 nicotinic acetylcholine receptors by rat adrenal chromaffin cells determined using novel conopeptide antagonists.

Authors:  Arik J Hone; Lola Rueda-Ruzafa; Thomas J Gordon; Joanna Gajewiak; Sean Christensen; Tino Dyhring; Almudena Albillos; J Michael McIntosh
Journal:  J Neurochem       Date:  2020-02-11       Impact factor: 5.372

Review 10.  Diverse strategies targeting α7 homomeric and α6β2* heteromeric nicotinic acetylcholine receptors for smoking cessation.

Authors:  Darlene H Brunzell; J Michael McIntosh; Roger L Papke
Journal:  Ann N Y Acad Sci       Date:  2014-04-14       Impact factor: 5.691

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.